Teva Pharmaceutical Industries (NYSE:TEVA) shares continued gains for seven straight sessions, as the stock closed 1% higher at $16.59 on Tuesday.
The Israeli drugmaker gained about 5% in the preceding six sessions. The stock has lost more than 25% so far this year, compared